IPG: Inflammatory Bowel Disease Chaired by Bruce Sands, MD


This edition of HCPLive® State of the Science involves 3 experts discussing different trends in IBD treatments and care.

A trio of clinicians recently came together to present data and expertise on a variety of issues related to inflammatory bowel disease (IBD) treatments.

On June 10, Bruce E. Sands, MD, Chief of the Dr. Henry D. Janowitz Division of Gastroenterology at Mount Sinai Hospital and the Dr. Burrill B. Crohn Professor of Medicine (Gastroenterology), led the HCPLive® State of the Science Event called Institutional Perspectives in Gastroenterology: Inflammatory Bowel Disease.

Joined by Ryan Ungaro, MD, Assistant Professor of Medicine in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai and Jean-Frederic Colombel, MD, Director Inflammatory Bowel Disease Center Icahn School of Medicine at Mount Sinai, the trio discussed the following topics:

  • Managing IBD During COVID-19
  • Early Use of Biologics
  • Emerging Therapies: Newer Biologic Therapies
  • Emerging Therapies: The Return of Small Molecules
Related Videos
HCPLive Five at APA 2024 | Image Credit: HCPLive
John M. Oldham, MD: A History of Personality Disorder Pathology
Franklin King, MD: Psychedelic Therapy History, Advances, and Hurdles
Robert Weinrieb, MD: Psychiatry-Hepatology Approach for Alcohol-Related Liver Disease
© 2024 MJH Life Sciences

All rights reserved.